prosterid 1 mg
2care4 generics aps - finasterid - tablett, filmdrasjert - 1 mg
fingolimod tillomed 0.5 mg
tillomed pharma gmbh - schönefeld - fingolimodhydroklorid - kapsel, hard - 0.5 mg
condyline 5 mg/ ml
galderma nordic ab - podofyllotoksin - liniment, oppløsning - 5 mg/ ml
daktacort 20 mg/ g / 10 mg/ g
mcneil sweden ab - mikonazolnitrat / hydrokortison - krem - 20 mg/ g / 10 mg/ g
duodart 0.5 mg / 0.4 mg
glaxosmithkline as - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
dutasteride/tamsulosin orion 0.5 mg / 0.4 mg
orion corporation - espoo - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
dutasteride/tamsulosin medical vally 0.5 mg / 0.4 mg
medical valley invest ab - dutasterid / tamsulosinhydroklorid - kapsel, hard - 0.5 mg / 0.4 mg
tibolon aristo 2.5 mg
aristo pharma gmbh - tibolon - tablett - 2.5 mg
isentress
merck sharp & dohme b.v. - raltegravir - hiv-infeksjoner - antivirale midler til systemisk bruk - isentress er indisert i kombinasjon med andre anti-retroviral legemidler for behandling av humant immunsviktvirus (hiv-1) infeksjon.
braftovi
pierre fabre medicament - encorafenib - melanoma; colorectal neoplasms - antineoplastiske midler - encorafenib is indicated:in combination with binimetinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutationin combination with cetuximab, for the treatment of adult patients with metastatic colorectal cancer (crc) with a braf v600e mutation, who have received prior systemic therapy.